Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026, Mar 2026, Apr 2026, May 2026 and Jul 2026.
- Largest single sale: $130K (200 shares) of Regeneron Pharmaceuticals on Jul 2, 2026. Filing
- Last sale before this period: Oct 1, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | Director | Jan 6, 2004 | Jul 7, 2026 |
| Citizens Financial Group (CFG) | Former Director | Sep 30, 2014 | Feb 15, 2019 |
| Prudential Financial (PRU) | Former Chairman, Director | Dec 22, 2003 | Feb 14, 2008 |
Also a director at
Citizens Financial Group (CFG) (no filing in the last 18 months), Prudential Financial (PRU) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 2, 2026, Regeneron Pharmaceuticals: sold 200 shares for $130K, under a disclosed plan. 1 filing: 1
- May 1, 2026, Regeneron Pharmaceuticals: sold 100 shares for $71K, under a disclosed plan. 1 filing: 1
- Apr 1, 2026, Regeneron Pharmaceuticals: sold 100 shares for $78K, under a disclosed plan. 1 filing: 1
- Mar 2, 2026, Regeneron Pharmaceuticals: sold 100 shares for $79K, under a disclosed plan. 1 filing: 1
- Feb 9, 2026, Regeneron Pharmaceuticals: sold 100 shares for $78K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.